BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38067141)

  • 21. Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44
    Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M; Zargar Balajam N
    Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28370734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis.
    Firouzi J; Sotoodehnejadnematalahi F; Shokouhifar A; Rahimi M; Sodeifi N; Sahranavardfar P; Azimi M; Janzamin E; Safa M; Ebrahimi M
    Bioimpacts; 2022; 12(5):415-429. PubMed ID: 36381630
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
    Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
    PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells.
    Zhang L; Wang H; Li C; Zhao Y; Wu L; Du X; Han Z
    Cell Physiol Biochem; 2017; 44(3):1251-1262. PubMed ID: 29179185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Essential Oil of
    Bakhtiarpoor M; Setorki M; Kaffashian MR
    Iran J Med Sci; 2018 Jul; 43(4):409-415. PubMed ID: 30046210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.
    Wang L; Guo H; Yang L; Dong L; Lin C; Zhang J; Lin P; Wang X
    Mol Cell Biochem; 2013 Jul; 379(1-2):7-18. PubMed ID: 23543150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells.
    Buommino E; Tirino V; De Filippis A; Silvestri F; Nicoletti R; Ciavatta ML; Pirozzi G; Tufano MA
    Cell Prolif; 2011 Oct; 44(5):401-9. PubMed ID: 21951283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
    Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
    Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer.
    Rahimi M; Sharifi-Zarchi A; Zarghami N; Geranpayeh L; Ebrahimi M; Alizadeh E
    Cell J; 2020 Jan; 21(4):467-478. PubMed ID: 31376329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition.
    Nallanthighal S; Elmaliki KM; Reliene R
    Nutr Cancer; 2017 Oct; 69(7):1088-1098. PubMed ID: 28976208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
    Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell-like Properties.
    Chen C; Okita Y; Watanabe Y; Abe F; Fikry MA; Ichikawa Y; Suzuki H; Shibuya A; Kato M
    Cancer Res; 2018 Nov; 78(22):6424-6435. PubMed ID: 30224376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.
    Sousa N; Geiß C; Bindila L; Lieberwirth I; Kim E; Régnier-Vigouroux A
    BMC Cancer; 2023 Aug; 23(1):762. PubMed ID: 37587449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.